Seminar Presentations

Meaningful Benefit at Minimal Risk — The Frailty Phenotype

Thanks go to Dr Linda Fried, Dean of Mailman School of Public Health and Vice-President, Columbia University, for the GNYGCC seminar, Meaningful Benefit at Minimal Risk — The Frailty Phenotype.

This seminar focused on the frailty syndrome which Dr. Fried and colleagues operationalized in the Cardiovascular Health Study as a useful means of evaluating older adults. She articulated the syndrome of frailty and the Unmet Needs of Frailty assessment and consideration in Cardiovascular care.

View the entire presentation, Meaningful Benefit at Minimal Risk — The Frailty Phenotype at this link.

The complete slide set is available here.

Take the Pre-Test.

Take the Post-Test.

Suggested Reading:

Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery. Circulation

Frailty as a predictor of surgical outcomes in older patients

Cardiovascular Health Study Research Group. Associations of subclinical cardiovascular disease with frailty

Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype

Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance

Learning Objectives:

1) Define the frailty phenotype
2) Distinguish frailty from disability and co-morbidity
3) Enumerate the methods available to define the frailty phenotype, the need for multi-dimensional assessment and whether the phenotype should include cognitive as well as physical assessments.
4) Enumerate how frailty assessment can be used to predict outcomes of older adults undergoing invasive procedures.
5) Delineate how assessment of frailty might be employed to manage risk for older adults with cardiovascular disease.
Recognize hazards of hospitalization and surgery for frail older adults and formulate appropriate prevention and treatment plans.
6) Enumerate at least three unmet needs in the area that are ripe for multicenter collaboration.

Aging & Pharmacology

Dr Janice Schwartz is professor of clinical medicine in bioengineering and therapeutic sciences at UCSF, and also the director of research at Jewish Home in San Francisco.  

View her presentation on
Aging and Pharmacology at this link.

Please refer to a corrected slide #12 to address an error in the original presentation of the Cockcroft & Gault formula.

Take the Pre-Test

Take the Post-Test

Suggested Reading:
The Current State of Knowledge on Age, Sex, and Their Interactions on Clinical Pharmacology

Learning Objectives:

1. Describe age-related declines in body size, composition, renal elimination, and enzymatic metabolism and how these changes affect medication dosing
2. Recognize the risks of therapy involving multiple medications (polypharmacy)
3. Conceptualize a framework for minimizing polypharmacy
4. Identify unmet needs and knowledge gaps in our medication-based therapies for cardiac conditions of older people

Cardiovascular Syndromes in Older Adults

Dr. Mat Maurer, GNYGCC Founder, experienced researcher, clinician and educator explained the value of delineating the work of both Geriatrics and Cardiology in terms of syndromes, rather than disease.  He further elucidated the significant impact of syndromes on outcomes and the greater predictive value of these in respect to clinical markers.

View Dr Maurer’s lecture at:
Cardiovascular Syndromes in the Older Adult

TAKE THE POST-TEST HERE

TAKE THE PRE-TEST HERE

See the complete slide set at:
Cardiovascular Syndromes in Older Adults’

Suggested Readings:

Geriatric Syndromes: Clinical, Research and Policy Implications of a Core Geriatric Concept

Prevalence of geriatric syndromes and impact on clinical and functional outcomes in older patients with acute cardiac diseases

Self-Reported Lack of Energy (Anergia) Among Elders in a Multiethnic Community

Combined Impact of Geriatric Syndromes and Cardiometabolic disesase on Measures of Functional Impairment

Seminar Objectives:

Upon completion of this module, the reader will be able to:

  1. Enumerate criteria for defining “geriatric syndromes”
  2. Understand the added value added in moving away from a “disease based model” to a more complex paradigm involving syndromes.
  3. Delineate common “geriatric cardiovascular syndromes”.
  4. Identify shared risk factors among “geriatric syndromes”
  5. Highlight the prevalence of “geriatric syndromes” in older adults with cardiovascular disease and their independent association with outcomes.
  6. List obstacles to geriatric assessment not being part of routine clinical care for older adults with cardiovascular disease.

GNYGCC Kick-Off Event

~100 trainees and instructors, members and guests, presenters and staff gathered at the Heart Center auditorium of Columbia University Medical Center to launch GNYGCC !

CLICK HERE to see and hear the presentations for yourself!